Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity

衰老和帕金森病:治疗模型和神经系统合并症

基本信息

  • 批准号:
    7937865
  • 负责人:
  • 金额:
    $ 120.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

Aging and Parkinson's disease: Models of therapeutics and neurologic comorbidity. This is an A2 application for a Udall Parkinson's Disease Center of Excellence from the University of Cincinnati directed by Timothy J. Collier, Ph.D. Two less studied aspects of Parkinson's disease (PD) are the neural mechanisms associated with development of adverse consequences of disease and treatment (such as depression and therapy-induced dyskinesias) and mechanisms associated with translational therapeutics (such as subthalamic nucleus DBS and progenitor ceU transplantation). In addition, it long has been appreciated that advancing age is a primary risk factor for PD, yet aging rarely is incorporated into experimental studies. Thus, the present proposal groups these topics under the rubric of "adaptive and maladaptive plasticity"and examines their expression in the context of advancing chronological age. The proposal consists of four projects and two cores that interconnect and serve the projects. Project 1 examines the roles of maladaptive changes in spine morphology in suboptimal recovery provided by grafted dopamine (DA) neurons and the development of therapy-induced dyskinesias. Project 2 will determine the degree and mechanism of neuroprotection for the DA system conferred by high frequency electrical stimulation of the subthalamic nucleus. In particular, stimulation effects on neurotrophic mechanisms wUl be examined. Project 3 tests the hypothesis that preservation of the structure and function of the injured nigrostriatal system following engraftment of undifferentiated neural progenitor ceUs is not a product of replacement of DA neurons by grafted cells, but is mediated by graft-induced protection and/or regeneration of mature host DA neurons. The goal of Project 4 is to gain insight into the co-mingling of PD, stress, anxiety and depression. It will test the hypothesis that comorbid depression exacerbates the behavioral deficits, neurochemical abnormalities, and neurodegeneration associated with PD via deleterious glucocorticoid mechanisms. AH projects will utilize well-established rat models and examine differences and similarities of mechanisms and outcomes in the context of advancing chronological age. To the extent that plasticity is characteristic of PD, it provides points of access to harness its therapeutic effects and curtail its negative effects.
衰老和帕金森氏病:治疗和神经系统合并症的模型。这是由蒂莫西·J·科利尔(Timothy J. Collier)博士执导的辛辛那提大学的Udall Parkinson病卓越中心的A2申请。帕金森氏病(PD)的两个较少研究的方面是与疾病和治疗不良后果的发展有关的神经机制(例如抑郁症和治疗诱导的运动障碍)以及与转化治疗(例如下allamic核DBS和祖先DBS和祖先CEU CEU)相关的机制。此外,长期以来,人们一直认为,前进的年龄是PD的主要危险因素,但衰老很少被纳入实验研究中。因此,本提案将这些主题分组为“适应性和适应性可塑性”的标题,并在促进时间顺序时代的背景下检查了它们的表达。该提案由四个项目和两个核心组成,它们相互连接并为项目提供服务。项目1研究了脊柱形态的不良适应性变化在嫁接多巴胺(DA)神经元提供的次优恢复中的作用以及治疗引起的运动障碍的发展。项目2将确定由丘脑下核的高频电刺激赋予的DA系统的神经保护程度和机制。特别是,可以检查对神经营养机制的刺激作用。项目3检验了以下假设:在植入未分化的神经祖细胞CEUS CEUS植入后受伤的黑质体系的结构和功能并不是接枝细胞替换DA神经元的产物,而是由移植物诱导的保护和/或Mature宿主DA神经元的介导的。项目4的目标是深入了解PD,压力,焦虑和抑郁的共同融合。它将检验以下假设,即合并症抑郁加剧了通过有害的糖皮质激素机制与PD相关的行为缺陷,神经化学异常和神经变性。 AH项目将利用良好的大鼠模型,并在延长时间顺序的年龄的背景下检查机制和结果的差异和相似之处。在一定程度上,可塑性是PD的特征,它提供了利用其治疗效果并减少其负面影响的访问点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy J. Collier其他文献

Entorhinal cortex electrical stimulation disrupts retention performance when applied after, but not during, learning
  • DOI:
    10.1016/0006-8993(78)90274-3
  • 发表时间:
    1978-08-25
  • 期刊:
  • 影响因子:
  • 作者:
    Timothy J. Collier;Aryeh Routtenberg
  • 通讯作者:
    Aryeh Routtenberg
Intracranial self-stimulation derived from entorhinal cortex
  • DOI:
    10.1016/0006-8993(77)91025-3
  • 发表时间:
    1977-11-25
  • 期刊:
  • 影响因子:
  • 作者:
    Timothy J. Collier;Scott Kurtzman;Aryeh Routtenberg
  • 通讯作者:
    Aryeh Routtenberg

Timothy J. Collier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy J. Collier', 18)}}的其他基金

Circadian disruption as an accelerator of synucleinopathy
昼夜节律紊乱是突触核蛋白病的加速因素
  • 批准号:
    10572194
  • 财政年份:
    2022
  • 资助金额:
    $ 120.13万
  • 项目类别:
Nortriptyline-mediated attenuation of alpha-synuclein pathology in Parkinson's disease
去甲替林介导的帕金森病α-突触核蛋白病理学减弱
  • 批准号:
    9763677
  • 财政年份:
    2015
  • 资助金额:
    $ 120.13万
  • 项目类别:
Nortriptyline-mediated attenuation of alpha-synuclein pathology in Parkinson's disease
去甲替林介导的帕金森病α-突触核蛋白病理学减弱
  • 批准号:
    9137744
  • 财政年份:
    2015
  • 资助金额:
    $ 120.13万
  • 项目类别:
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
衰老和帕金森病:治疗模型和神经系统合并症
  • 批准号:
    8326662
  • 财政年份:
    2009
  • 资助金额:
    $ 120.13万
  • 项目类别:
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
衰老和帕金森病:治疗模型和神经系统合并症
  • 批准号:
    7694509
  • 财政年份:
    2009
  • 资助金额:
    $ 120.13万
  • 项目类别:
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
衰老和帕金森病:治疗模型和神经系统合并症
  • 批准号:
    8532050
  • 财政年份:
    2009
  • 资助金额:
    $ 120.13万
  • 项目类别:
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
衰老与帕金森病:治疗模型和神经系统合并症
  • 批准号:
    8792679
  • 财政年份:
    2009
  • 资助金额:
    $ 120.13万
  • 项目类别:
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
衰老和帕金森病:治疗模型和神经系统合并症
  • 批准号:
    8142809
  • 财政年份:
    2009
  • 资助金额:
    $ 120.13万
  • 项目类别:
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
衰老与帕金森病:治疗模型和神经系统合并症
  • 批准号:
    8991960
  • 财政年份:
    2009
  • 资助金额:
    $ 120.13万
  • 项目类别:
ASNTR Annual Meeting Student Travel Awards
ASNTR 年会学生旅行奖
  • 批准号:
    7492462
  • 财政年份:
    2008
  • 资助金额:
    $ 120.13万
  • 项目类别:

相似国自然基金

温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
  • 批准号:
    12302265
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
  • 批准号:
    52308322
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
  • 批准号:
    52373051
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
  • 批准号:
    42377282
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
  • 批准号:
    52376132
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

The Influence of Habitual Physical Activity and Diet in the Development of Sarcopenia Among Older Adults With HIV
习惯性体力活动和饮食对老年艾滋病毒感染者肌肉减少症发展的影响
  • 批准号:
    10699259
  • 财政年份:
    2023
  • 资助金额:
    $ 120.13万
  • 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
  • 批准号:
    10588414
  • 财政年份:
    2023
  • 资助金额:
    $ 120.13万
  • 项目类别:
Family caregivers in later life: A longitudinal study of well-being and mental health in families of adults with autism and developmental disabilities
晚年的家庭照顾者:对患有自闭症和发育障碍的成年人的家庭福祉和心理健康的纵向研究
  • 批准号:
    10588105
  • 财政年份:
    2023
  • 资助金额:
    $ 120.13万
  • 项目类别:
Pain sensitivity and endogenous pain modulation in autistic adults
自闭症成人的疼痛敏感性和内源性疼痛调节
  • 批准号:
    10574757
  • 财政年份:
    2023
  • 资助金额:
    $ 120.13万
  • 项目类别:
Cognitive Health and Modifiable Factors of Daily Sleep and Activities Among Dementia Family Caregivers
痴呆症家庭护理人员的认知健康状况以及日常睡眠和活动的可改变因素
  • 批准号:
    10643624
  • 财政年份:
    2023
  • 资助金额:
    $ 120.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了